Search company, investor...
Epocrates company logo


Founded Year



Acq - P2P | Acquired

Total Raised






About Epocrates

Epocrates is a provider of mobile drug reference tools to healthcare professionals and interactive services to the healthcare industry. Most commonly used on mobile devices at the point of care, the company's products help healthcare professionals make more informed prescribing decisions, enhance patient safety and improve practice productivity. Epocrates' user network consists of healthcare professionals. The company offers products on all major U.S. mobile platforms including Apple R (iPhone, iPod touch and iPad), Android, BlackBerry, Palm and Windows Mobile devices.

Headquarters Location

1100 Park Place Suite 300

San Mateo, California, 94403,

United States

(650) 227-1700

Missing: Epocrates's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Epocrates's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Epocrates Patents

Epocrates has filed 5 patents.

patents chart

Application Date

Grant Date


Related Topics




Pharmaceuticals policy, Pharmaceutical industry, Health informatics, Amines, Medical terminology


Application Date


Grant Date



Related Topics

Pharmaceuticals policy, Pharmaceutical industry, Health informatics, Amines, Medical terminology



Latest Epocrates News

epocrates Launches Bugs + Drugs Tool to Promote Optimal Antibiotic Prescribing

Sep 12, 2022

What You Should Know: – epocrates, an athenahealth, Inc. company that delivers digital clinical decision support to healthcare professionals, today announced the release of Bugs + Drugs, a mobile tool that offers clinicians information about bacteria types and antibacterial susceptibility patterns by ZIP code. – A free feature in the epocrates mobile app, the tool supports clinicians in choosing appropriate empiric antibiotics for each patient at the point of care. Data-Driven Tools to Improve Care in the Ambulatory Setting Since 1998, epocrates, an athenahealth, Inc. company, has served essential, clinical content to more than one million physicians, nurses, pharmacists and other healthcare professionals. Centered around unparalleled drug prescribing and safety information, the app provides fast answers and trusted decision support in seconds at the point of care, enabling clinicians to focus on delivering the most effective and personalized patient care. According to the Center for Disease Control and Prevention (CDC) pre-pandemic report, antibiotic-resistant infections exceed 2.8 million annually in the United States, resulting in more than 35,000 deaths annually. To address the growing threat of resistance, one key tenet of antimicrobial stewardship involves factoring local resistance and susceptibility patterns into antibiotic prescribing decisions. Inpatient settings typically publish bacterial susceptibility data relevant to their hospital; however, antimicrobial susceptibility data are not widely aggregated and made publicly available in the outpatient setting. Without such data, clinicians must rely on their empirical knowledge to make antibiotic prescribing selections. Decisions made for individual patients hold the potential to fuel bacterial resistance trends for the future. The tool’s features include a list of bacteria observed in urine, skin, and other sample types aggregated by ZIP code. For each organism, the tool presents relevant antibiotic drug options with corresponding susceptibilities, linked seamlessly to epocrates’ trusted drug content, which includes dosing, drug interaction details, and safety information. “At a time when antimicrobial resistance is on the rise, Bugs + Drugs fills a major gap in the outpatient setting. Historically, clinicians have had to make educated guesses about the prevalence of various bacteria and whether those organisms are susceptible or resistant to various antibiotics, and they generally err on the side of prescribing antibiotics that are too broad,” said Anne Meneghetti, MD, executive director of Medical Information, epocrates. “With Bugs + Drugs, clinicians now have an innovative, digital tool in their pocket that offers localized susceptibility data needed to confidently make informed and effective point-of-care decisions for patients through knowledge of the bacteria prevalent in their patient’s community.” Bugs + Drugs’ methods and apparatus for tracking antimicrobial susceptibility based on geography is a patented process. The data are sourced from de-identified microbiology data from athenaClinicals, athenahealth’s cloud-based electronic health record, used predominantly by ambulatory care organizations. With a nationwide network of more than 145,000 clinicians and serving approximately 20% of the U.S. population, athenahealth provides insights from vast data that enable a unique and extensive view into health trends to support optimal decision-making at the point of care.

Epocrates Frequently Asked Questions (FAQ)

  • When was Epocrates founded?

    Epocrates was founded in 1998.

  • Where is Epocrates's headquarters?

    Epocrates's headquarters is located at 1100 Park Place, San Mateo.

  • What is Epocrates's latest funding round?

    Epocrates's latest funding round is Acq - P2P.

  • How much did Epocrates raise?

    Epocrates raised a total of $40M.

  • Who are the investors of Epocrates?

    Investors of Epocrates include athenahealth, Goldman Sachs, InterWest Partners, Sprout Group, Threshold Ventures and 7 more.

  • Who are Epocrates's competitors?

    Competitors of Epocrates include PatientKeeper and 6 more.

Compare Epocrates to Competitors


EVERSANA is an independent provider of global services to the life science industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product lifecycle to deliver long-term, sustainable value for patients, prescribers, channel partners, and payers. The company serves organizations, including start-ups and established pharmaceutical companies to advance life science solutions. The firm was founded in 2014 and is based in Milwaukee, Wisconsin.

Airstrip Technologies

AirStrip seeks to make improvements in worldwide healthcare delivery by creating technology for caregivers to collaborate and care for their patients. AirStrip provides a complete, vendor and data source-agnostic, enterprise-wide mobile interoperability platform that advances care collaboration.


UpHill is making healthcare safer by delivering training and performance analysis software.

Sermo Logo

Sermo offers an online community for physicians to exchange observations and knowledge. Physicians use the company's website to aggregate observations from their daily practice and then challenge or corroborate each others' opinions, accelerating the emergence of trends and new insights on medications, devices, and treatments.

Amboss Logo

AMBOSS is a medical education company that aims to change the way physicians acquire their know-how. Its comprehensive study and reference tool combines technology with new research and helps students to use interactive libraries and question banks for general study and exam preparation. The company was founded in 2013 and is based in Berlin, Germany.


MedShr is an easy and safe way for medical professionals to discover, discuss and share clinical cases and medical images.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.